SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Phil Cressman who wrote (1254)7/7/1998 10:19:00 PM
From: Rudy Saucillo  Read Replies (1) | Respond to of 2742
 
One important point...the extent of the deal isn't clear to me from the press release, but the agreement covers more than flu. Probably covers a number of infectious disease vaccines that Connaught would like to evaluate with the IL-1b adjuvant. Probably doesn't cover applications under the old GTI sublicense - which means the cancer applications may still be available for partnership. Rudy